GE
Free New Zealand in Food & Environment, 17th July 2003
Time to rethink �animal bioreactors� as thousands of sheep set for
slaughter.
The decision to slaughter the PPL experimental sheep is a regrettable outcome of flawed
science, and misleading claims to investors, by sectors of the biotech industry. Concern for
the animals to be humanely destroyed, and safely disposed of in ways that will not
contaminate soil or the environment, remain the duty of ERMA.
The Biotech industry have pushed overseas for meat from experimental animals to be sold as
food, but any attempt to have that happen here is completely unacceptable. The PPL sheep
must not be allowed to enter the food chain. However the disappointment amongst parents of
sick children, sold on the idea that these sheep would cure their children, needs also to
be addressed.
Parents do not seem to have been told that clinical trials
of the chemical to be mass-produced in the sheep had already failed some years ago. This failure is likely to have prompted investor-concern about
PPL�s business, though the parents continued to defend the production of these GE sheep and it appears they had not been told of the failed trials.
It is time the biotech industry considered the more ethical alternatives to using mammals as factories for Pharmaceuticals. As well as research
into prevention of disease, alternative research should be funded that avoids the unethical and cruel abuse of animals, and presents less
bio-security risk by keeping organisms in contained labs. Independent scientists have suggested use of yeasts and fungi could be a real
alternative for research into production of complex proteins and it is time these alternatives are
considered. The Royal Commission on GM recommended alternatives to use of food-animals as � bioreactors�, should
be explored. This redirection of research in New Zealand could offer the benefits of ethical gene technology to our �knowledge economy� without
sacrificing our environment, brand image, or basic human values.
The decline of PPL and other companies in the biotech sector is starting to
resemble the demise of the dot.com companies and it is vital that cowboy-science is now replaced
by ethical science aimed at genuine understanding and not just quick profits.
Contact Jon Carapiet 09 815
3370
Back to
Press Release Directory
Hamilton, July 16 NZPA -
The Scottish biotech company behind the world's first cloned sheep has confirmed it will slaughter sheep carrying human
genes farmed in Waikato.
PPL Therapeutics, which became famous in 1996 after it cloned Dolly the
sheep, began New Zealand's first field trial of genetically modified animals in 1996. It inserted human
genes into sheep at its 170ha Whakamaru research farm with the aim of producing the human protein AAT in sheep's
milk which can be used in medicines to treat cystic fibrosis and emphysema. However, the work was put on hold after its partner, German
pharmaceutical giant Bayer, pulled the plug on the trials, saying they were too costly.
PPL said yesterday it was to slaughter up to 3000
genetically modified sheep at its two farms in Scotland, but had not confirmed how many of the Whakamaru flock, made up
of about 3000 genetically modified sheep and 1000 normal sheep, will be killed.
"Unfortunately, placing the AAT programme on hold has also meant that PPL can no longer support all its AAT sheep flock, and work is under way to
reduce sheep numbers on its farms in both Scotland and New Zealand," a PPL spokeswoman told a Scottish newspaper. The jobs of 17 people employed at
Whakamaru, including nine farm workers and eight administrators, are in question.
Hamilton-based AgResearch's commercial arm, Celentis, has expressed interest in taking over the Whakamaru operation. However, chief executive
Stewart Washer said it was "early days" and it had to first get backing from both PPL and its partner Bayer. PPL has to tell the Environment Risk
Management Authority (Erma) before it slaughters any genetically modified sheep, and the slaughter must be carried out according to strict Erma
rules. The sheep with human genes would have to be incinerated while the normal sheep must be buried on site.
Back to
Press Release Directory
|